Article Sidebar

pdf
Date Published: 09/09/2023
Abstract Views: 187
Views pdf: 117
DOI: https://doi.org/10.51298/vmj.v529i2.6496
Issue
Vol. 529 No. 2 (2023)
Section
Các bài báo
How to Cite
Võ , T. A., Phạm, T. B. Đào, & Phan, S. A. Q. (2023). SCOPING REVIEW TREATMENT RESULTS OF SUDDEN HEARING LOSS WITH SYSTEMIC CORTICOSTEROID. Vietnam Medical Journal, 529(2). https://doi.org/10.51298/vmj.v529i2.6496

SCOPING REVIEW TREATMENT RESULTS OF SUDDEN HEARING LOSS WITH SYSTEMIC CORTICOSTEROID

Thế Anh Võ 1,, Thị Bích Đào Phạm2, Sỹ Anh Quế Phan3
1 Nghe An obstetrics and pediatrics hospital
2 HMU
3 Nghe An Cancer Hospital

Main Article Content

Abstract

Aim: Results of systemic corticosteroid therapy in sudden sensorineura hearing loss. Materials and methods: A reView of research articles on the results of systemic corticosteroid treatment in sudden sensorineura hearing loss on the Pubmed, Cochrane, Sciencedirect databases with two independent and consistent eValuations by two researchers. Results: From 550 articles found, 29 articles met the selection criteria for inclusion in the study. Systemic corticosteroids used in the study were Prednisone, Methyperdnisolone, Dexamethasone orally, intraVenously or in combination. With a gradually decreasing dose oVer the course of 1 to 2 weeks of treatment. With the eValuation criteria PTA after treatment > 10 dB has a recoVery rate from 38% to


88.5 % and PTA after treatment decreases > 15 dB has a recoVery rate from 53% to 87% but there is no consensus in PTA calculation, follow-up time, eValuation criteria. Conclusions: Systemic corticosteroids are an accepted treatment because of their recoVery rate of about 38% to 88.5% (Post- treatment PTA >10 dB) and safety. Consider systemic corticosteroid therapy in combination with transatrial corticosteroids for patients with sudden high- frequency deafness and poor prognosis

Article Details

Keywords

Sudden hearing loss, Sudden sensorineura hearing loss, systemic corticosteroids, treatment results

References

TÀI LIỆU THAM KHẢO
1. Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngol Neck Surg. 2019;161(S1):S1-S45. doi:10.1177/0194599819859885
2. Dallan I, Fortunato S, Casani AP, et al. Long- term follow up of sudden sensorineural hearing loss patients treated with intratympanic steroids: audiological and quality of life eValuation. J Laryngol Otol. 2014;128(8):669-673. doi:10.1017/S0022215114001595
3. Al-Shehri A. Intratympanic Vs. Oral Steroids for Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Controlled Study. Br J Med Med Res. 2016;11(6):1-6. doi:10.9734/BJMMR/2016/21732
4. Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospectiVe double-blind study. Eur Arch Otorhinolaryngol. 2001;258(9):477-480. doi:10.1007/s004050100366
5. Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid Treatment of Idiopathic Sudden Sensorineural Hearing Loss: Randomized Triple- Blind Placebo-Controlled Trial. 2012;33(4):9.
6. Hultcrantz E, Nosrati-Zarenoe R. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: analysis of an RCT and material drawn from the Swedish national database. Eur Arch Otorhinolaryngol. 2015;272(11):3169-3175. doi:10.1007/s00405-014-3360-4
7. Wei BP, Stathopoulos D, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss.



Cochrane Database Syst ReV. 2013;(7). doi:10.1002/14651858.CD003998.pub3
8. Ahmadzai N, Kilty S, Cheng W, et al. A systematic reView and network meta-analysis of

existing pharmacologic therapies in patients with idiopathic sudden sensorineural hearing loss. PLoS ONE. 2019;14(9):e0221713.
doi:10.1371/journal.pone.0221713